Project Grant R61HL184905
Award Date 9/1/26
Completion Date 8/31/27
Dollars Obligated $511K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded Oregon Health & Science University $2,141,996 on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and implement Community Vital Signs (CVS) strategies for identifying undiagnosed hypertension in Nigeria. The project adapts community-based screening interventions to increase blood pressure screening among adults over 18 years of age and connect patients to primary care for hypertension...
- The National Heart, Lung, and Blood Institute awarded Icahn School of Medicine at Mount Sinai $672,958 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct research on task-shifting models for hypertension care in low-resource rural settings. The research project, titled "Task-Shifting at the Doorstep of the People: Strengthening the Hypertension Care Continuum Within Primary Health Care in a Low-Resource Setting," develops and tests...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of California, San Francisco $3,093,164 on June 10, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate an expanded HIV Synthesis microsimulation model incorporating hypertension and cardiovascular disease outcomes, evaluate health effects and cost-effectiveness of implementation strategies for HIV-hypertension care integration across West, East, and Southern Africa...
- The National Heart, Lung, and Blood Institute awarded Emory University $783,830 under the Cardiovascular Diseases Research program (CFDA 93.837) on July 15, 2026, to conduct a prospective cohort study examining vascular endothelial function, ovarian hormones, inflammatory response, and hypertension incidence in women of reproductive age with and without HIV. The project, titled HIV and Endothelial Function in Women of Reproductive Age (HEART), will enroll 400 participants from Atlanta and...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Alabama at Birmingham $223,438 on September 4, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a clinical research study examining hypertension incidence in people with HIV initiating antiretroviral therapy (ART). The project, scheduled for completion by August 31, 2027, will assess blood pressure outcomes in ART-naïve individuals starting either...
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $908,994 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to test implementation strategies for electronic health record-based interventions to improve hypertension control in primary care settings. The project builds on the recipient's prior NIH-funded REDUCE-BP trial, which enrolled 49,210 patients and 560 primary care providers and demonstrated that multi-component...
- The National Heart, Lung, and Blood Institute awarded The Johns Hopkins University $366,914 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 1, 2026, for a five-year prospective cohort study examining cardiometabolic outcomes in women living with HIV on dolutegravir-based antiretroviral therapy. The study will compare cardiometabolic complications between women on dolutegravir-based and atazanavir/ritonavir-based antiretroviral regimens across reproductive life...
- The National Heart, Lung, and Blood Institute awarded the University of Mississippi Medical Center $333,250 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to adapt and pilot-test a home blood pressure monitoring intervention for rural Mississippi. The recipient will modify a validated chronic disease self-management program that combines longitudinal home blood pressure monitoring with a smartphone-delivered virtual agent providing personalized education. The...
- The National Heart, Lung, and Blood Institute awarded the University of Connecticut Health Center $155,452 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) for a five-year project grant (K01HL176409) to evaluate integrated HIV and non-communicable disease service delivery through mathematical modeling. The recipient will use mathematical modeling and data from the Center for Infectious Disease Research in Zambia's NIH-funded TASKPEN trial to assess the...
- The National Heart, Lung, and Blood Institute awarded New York University $847,163 on August 13, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and implement the Community-to-Clinic Implementation Program to Control Hypertension in Barbershops (CLIP HTN). The award funds a research initiative to test whether community health worker-delivered hypertension screening and linkage services delivered through barbershops improve blood pressure control and linkage to...